Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent

The C2 domain of synaptotagmin I, which binds to anionic phospholipids in cell membranes, was shown to bind to the plasma membrane of apoptotic cells by both flow cytometry and confocal microscopy. Conjugation of the protein to superparamagnetic iron oxide nanoparticles allowed detection of this binding using magnetic resonance imaging. Detection of apoptotic cells, using this novel contrast agent, was demonstrated both in vitro, with isolated apoptotic tumor cells, and in vivo, in a tumor treated with chemotherapeutic drugs.

[1]  D. Weber,et al.  Ultra-high-resolution imaging of small animals: Implications for preclinical and research studies , 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[2]  S. Singer,et al.  Iron-dextran antibody conjugates: General method for simultaneous staining of two components in high-resolution immunoelectron microscopy. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Blankenberg,et al.  Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. , 1997, Blood.

[4]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[5]  Anna Moore,et al.  In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.

[6]  T. Südhof,et al.  A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding. , 1993, The Journal of biological chemistry.

[7]  K. Brindle,et al.  Induction of apoptosis in two mammalian cell lines results in increased levels of fructose‐1,6‐Bisphosphate and CDP‐choline as determined by 31P MRS , 1998, Magnetic resonance in medicine.

[8]  R. Davis,et al.  In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[10]  D. Kabelitz.  Apoptosis, graft rejection, and transplantation tolerance. , 1998, Transplantation.

[11]  K. Ang,et al.  Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. , 1993, International journal of radiation biology.

[12]  C. Culmsee,et al.  Apoptotic and antiapoptotic mechanisms in stroke , 2000, Cell and Tissue Research.

[13]  Jimmy D Bell,et al.  Characterisation of secondary metabolites associated with neutrophil apoptosis , 1996, FEBS letters.

[14]  Risto A. Kauppinen,et al.  1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: Implications for the in vivo detection of apoptosis , 1999, Nature Medicine.

[15]  C. Bortner,et al.  A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.

[16]  L. Milas,et al.  Apoptosis in murine tumors treated with chemotherapy agents. , 1995, Anti-cancer drugs.

[17]  Z. Darżynkiewicz,et al.  A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. , 1994, Analytical biochemistry.

[18]  A. Lazaris,et al.  HISTOLOGICAL ASSESSMENT OF APOPTOTIC CELL DEATH IN CARDIOMYOPATHIES , 2000, Pathology.

[19]  R. Kauppinen,et al.  Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. , 1998, Cancer gene therapy.

[20]  L. Benítez-Bribiesca.  [Apoptosis in the pathogenesis and treatment of disease]. , 1995, Gaceta medica de Mexico.

[21]  R Weissleder,et al.  Monocrystalline iron oxide nanocompounds (MION): Physicochemical properties , 1993, Magnetic resonance in medicine.

[22]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[23]  Ralph Weissleder,et al.  Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.

[24]  Y. Kitamoto,et al.  Early radiation effects in highly apoptotic murine lymphoma xenografts monitored by 31P magnetic resonance spectroscopy. , 1998, International journal of radiation oncology, biology, physics.

[25]  H. Karasuyama,et al.  Exposure of phosphatidylethanolamine on the surface of apoptotic cells. , 1997, Experimental cell research.

[26]  S. Sprang,et al.  Structure of the first C2 domain of synaptotagmin I: A novel Ca2+/phospholipid-binding fold , 1995, Cell.

[27]  J Keegan,et al.  Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography , 1999, Journal of magnetic resonance imaging : JMRI.